查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967716

臨床試驗生物樣本庫及存檔解決方案市場－全球產業規模、佔有率、趨勢、機會、預測：按服務、產品、地區和競爭對手分類，2021-2031年

Clinical Trial Biorepository & Archiving Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Product, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球臨床試驗生物樣本庫和存檔解決方案市場預計將從 2025 年的 41.9 億美元成長到 2031 年的 62.6 億美元，複合年成長率為 6.92%。

該領域涵蓋生物檢體和臨床研究數據的安全收集、處理、儲存和長期管理所需的基礎設施和服務。推動該領域發展的主要因素包括：對個人化醫療日益成長的需求（這需要高品質的生物樣本進行基因組分析），以及對資料完整性和可追溯性的嚴格監管要求。此外，藥物研發領域的大量資金投入也為此擴張提供了支持。根據歐洲製藥工業協會聯合會 (EFPIA) 的報告，到 2024 年，歐洲以研發為基礎的生物製藥產業在研發方面的投資金額約為 550 億歐元。

市場概覽
預測期 2027-2031
市場規模：2025年 41.9億美元
市場規模：2031年 62.6億美元
複合年成長率：2026-2031年 6.92%
成長最快的細分市場 生物樣本庫服務
最大的市場 北美洲

儘管成長勢頭強勁，但由於跨境生物材料運輸和儲存的法規環境複雜且分散，市場仍面臨許多障礙。遵守各種關於檢體處理和資料隱私的國際合規標準，會帶來巨大的物流挑戰和營運成本。這些監管障礙可能會阻礙全球存檔網路的順利發展，並使多區域臨床試驗的管理更加複雜。

市場促進因素

全球臨床試驗生物樣本庫和存檔解決方案市場成長的主要驅動力是生物製藥研發投資的激增。隨著製藥公司投入巨資研發新治療方法，需要合規且安全儲存的臨床試驗和生物檢體數量也隨之成長。這一趨勢在行業巨額支出中顯而易見。美國製藥製造商協會 (PhRMA) 於 2024 年 8 月發布的《2024 年會員調查》顯示，2023 年會員公司在研發方面的投資金額創下歷史新高，達到 1,035 億美元。因此，候選藥物研發管線不斷擴展，對第三方生物樣本庫服務的需求也日益成長，這些服務用於管理檢體儲存的物流。羅氏公司於 2024 年 2 月發布的《2023 年年度報告》進一步證實了這一現實，該報告顯示，羅氏的研發支出為 132 億瑞士法郎。

慢性疾病（尤其是腫瘤疾病）發生率的激增是另一個重要的市場促進因素，因為這需要進行複雜的縱向研究，而這些研究依賴高度可靠的生物樣本保存。隨著產業向精準腫瘤學轉型，長期保存血液和組織樣本以進行回顧性分析和生物標記發現的需求日益成長，這使得對專業保存技術的依賴性日益凸顯。全球疾病負擔的不斷加重進一步凸顯了這項需求的迫切性。國際癌症研究機構（IARC）在2024年2月的新聞稿中估計，到2050年，新增癌症病例將比2022年增加77%，超過3500萬例。疾病發生率的激增迫使贊助公司採用先進的保存系統，以確保樣本的長期存活，從而滿足監管標準和科學目標。

市場挑戰

跨境生物檢體儲存和運輸的監管框架分散且複雜，對市場造成了重大障礙。儲存服務和生物樣本庫依賴中心實驗室和採集點之間高效的檢體轉運，以維持樣本的完整性和數據的一致性。然而，各國關於生物主權和資料隱私的國際法律各不相同，需要嚴格的法律監管和複雜的物流協調。這種複雜性推高了營運成本，增加了運輸延誤的風險。這威脅到時效性生物材料的保存，並可能阻礙集中式全球檔案庫的建立。

這些監管壁壘對更廣泛的研究生態系統產生影響，導致研究停滯，尤其是在合規要求嚴格的地區。根據歐洲製藥工業協會聯合會（EFPIA）2024年的數據，歐洲在全球臨床試驗中所佔的佔有率從2013年的22%急劇下降至2023年的12%。這一下降凸顯了法規環境的碎片化如何扼殺臨床研究活動，從而降低了關鍵區域市場對整合式存檔和生物樣本庫解決方案的需求和有效性。

市場趨勢

重塑市場格局的一大趨勢是，企業策略性地轉向外包生物樣本庫和歸檔服務模式。這一趨勢的驅動力在於，製藥公司越來越傾向於營運柔軟性，而非維護資本密集的內部設施。臨床試驗申辦方日益依賴第三方供應商來維護合規的儲存記錄，並管理全球各地不同溫控區域所帶來的物流風險。這種轉變使企業能夠將固定儲存成本轉化為變動成本，同時也能利用穩定性測試通訊協定的專業知識。這種對外部支援的需求反映在財務表現中。 Cryoport在2024年3月公佈的數據顯示，其2023會計年度的生物儲存/生物服務業務收益年增45%，顯示第三方解決方案正被迅速採用。

同時，自動化儲存和搜尋系統（ASRS）的實施已成為提高搜尋速度和檢體完整性的關鍵營運重點。生物樣本庫正擴大利用先進的機器人基礎設施，以減少人為接觸樣本，並降低長期儲存過程中交叉污染和溫度偏差的風險。這些自動化平台對於管理現代治療研究至關重要的大量溫控材料至關重要。 Azenta 於 2024 年 8 月發布的 2024 年第三季財報也反映了這一市場向技術轉型的趨勢，該財報顯示，樣本管理解決方案的收入同比成長 7%，這主要得益於對低溫存儲平台和大規模自動化存儲平台的需求成長。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球臨床試驗生物樣本庫與存檔解決方案市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 特定服務（生物樣本庫服務、存檔解決方案服務）
    • 依產品分類（臨床前產品、臨床產品）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美臨床試驗生物樣本庫與存檔解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲臨床試驗生物樣本庫與存檔解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區臨床試驗生物樣本庫和存檔解決方案的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲臨床試驗生物樣本庫和存檔解決方案的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲臨床試驗生物樣本庫與存檔解決方案市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球臨床試驗生物樣本庫與存檔解決方案市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Azenta US, Inc.
  • Thermo Fisher Scientific Inc.
  • Precision for Medicine, Inc.
  • Medpace Holdings, Inc.
  • Laboratory Corporation of America Holdings
  • Q2 Solutions LLC
  • Labconnect Inc.
  • Charles River Laboratories International, Inc.
  • Cell&Co SAS
  • The Jackson Laboratory

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23960

The Global Clinical Trial Biorepository & Archiving Solutions Market is projected to expand from a valuation of USD 4.19 Billion in 2025 to USD 6.26 Billion by 2031, registering a CAGR of 6.92%. This sector comprises the essential infrastructure and services required for the secure collection, processing, preservation, and long-term management of biological specimens and clinical research data. Growth is primarily propelled by the intensifying demand for personalized medicine, which necessitates high-quality biospecimens for genomic profiling, alongside strict regulatory requirements for data integrity and traceability. Furthermore, significant financial investments in drug development underpin this expansion; as reported by the European Federation of Pharmaceutical Industries and Associations, the research-based biopharmaceutical sector in Europe invested approximately €55,000 million in R&D in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.19 Billion
Market Size 2031USD 6.26 Billion
CAGR 2026-20316.92%
Fastest Growing SegmentBiorepository Services
Largest MarketNorth America

Despite these positive growth trajectories, the market encounters substantial obstacles due to the complicated and fragmented regulatory environment regarding the cross-border transport and storage of biological materials. Adhering to varied international compliance standards for specimen handling and data privacy creates significant logistical challenges and operational costs. These regulatory barriers can hinder the seamless development of global archiving networks, complicating the management of multi-regional clinical trials.

Market Driver

A primary catalyst for the growth of the Global Clinical Trial Biorepository & Archiving Solutions Market is the surging investment in biopharmaceutical research and development. As pharmaceutical organizations dedicate vast resources to discovering new therapies, there is a proportional increase in the volume of clinical trials and biological samples that require compliant, secure storage. This trend is highlighted by substantial industry spending; the Pharmaceutical Research and Manufacturers of America's '2024 PhRMA Annual Membership Survey', released in August 2024, revealed that member companies invested a record $103.5 billion in R&D during 2023. Consequently, the pipeline of drug candidates is expanding, driving the need for third-party biorepository services to handle the logistics of specimen retention, a reality further illustrated by Roche's 'Annual Report 2023' from February 2024, which reported R&D expenditures of CHF 13.2 billion.

The escalating prevalence of chronic diseases, especially oncology, serves as another crucial market driver by necessitating complex longitudinal studies that depend on high-integrity biospecimen archiving. The industry's pivot toward precision oncology demands the long-term preservation of blood and tissue samples to facilitate retrospective analysis and biomarker discovery, establishing a reliance on specialized storage capabilities. The urgency of this requirement is underscored by the rising global disease burden; the International Agency for Research on Cancer estimated in a February 2024 press release that new cancer cases will increase by 77% from 2022 levels to over 35 million by 2050. This surge in disease incidence compels sponsors to implement advanced archiving systems that ensure sample viability over extended durations to satisfy both regulatory standards and scientific goals.

Market Challenge

The market faces significant impediments due to the fragmented and complex regulatory framework governing the cross-border storage and transportation of biological samples. Archiving services and biorepositories rely on the efficient transfer of specimens between central laboratories and collection sites to maintain sample integrity and data consistency. However, adherence to disparate international laws regarding biosovereignty and data privacy requires extensive legal oversight and sophisticated logistical coordination. These complexities drive up operational costs and heighten the risk of shipping delays, which can threaten the viability of time-critical biological materials and discourage the creation of centralized global archives.

The impact of these regulatory barriers extends to the broader research ecosystem, leading to stagnation in regions with particularly burdensome compliance requirements. Data from the European Federation of Pharmaceutical Industries and Associations in 2024 revealed that Europe's share of global clinical trials dropped significantly to 12% in 2023, down from 22% in 2013. This decline highlights how a disjointed regulatory environment can suppress clinical research activity, consequently reducing the demand for and efficacy of integrated archiving and biorepository solutions in key regional markets.

Market Trends

A prominent trend reshaping the market is the strategic transition toward outsourced archiving and biorepository service models, as pharmaceutical firms increasingly prioritize operational flexibility over maintaining capital-intensive internal facilities. Sponsors of clinical trials are turning to third-party providers to manage the logistical risks involved in maintaining compliant chain-of-custody documentation and diverse temperature zones across global locations. This shift allows companies to convert fixed storage costs into variable expenses while utilizing specialized expertise for stability protocols. The demand for such external support is reflected in financial results; Cryoport, Inc. reported in March 2024 that its BioStorage/BioServices revenue rose by 45% year-over-year in 2023, signaling the rapid adoption of third-party solutions.

Simultaneously, the integration of Automated Storage and Retrieval Systems (ASRS) has emerged as a vital operational priority to enhance retrieval speed and specimen integrity. Biobanks are increasingly utilizing advanced robotic infrastructure to limit human contact with samples, thereby mitigating risks of cross-contamination and temperature excursions during long-term storage. These automated platforms are indispensable for managing the expanding volume of temperature-sensitive materials essential for modern therapeutic research. The market's shift toward these technologies is evidenced by Azenta, Inc.'s 'Third Quarter Results for Fiscal 2024', released in August 2024, which showed a 7% year-over-year growth in Sample Management Solutions revenue, attributed specifically to the demand for cryogenic and large-automated storage platforms.

Key Market Players

  • Azenta U.S., Inc.
  • Thermo Fisher Scientific Inc.
  • Precision for Medicine, Inc.
  • Medpace Holdings, Inc.
  • Laboratory Corporation of America Holdings
  • Q2 Solutions LLC
  • Labconnect Inc.
  • Charles River Laboratories International, Inc.
  • Cell&Co SAS
  • The Jackson Laboratory

Report Scope

In this report, the Global Clinical Trial Biorepository & Archiving Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Trial Biorepository & Archiving Solutions Market, By Service

  • Biorepository Services
  • Archiving Solution Services

Clinical Trial Biorepository & Archiving Solutions Market, By Product

  • Preclinical Products
  • Clinical Products

Clinical Trial Biorepository & Archiving Solutions Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Clinical Trial Biorepository & Archiving Solutions Market.

Available Customizations:

Global Clinical Trial Biorepository & Archiving Solutions Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Trial Biorepository & Archiving Solutions Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Biorepository Services, Archiving Solution Services)
    • 5.2.2. By Product (Preclinical Products, Clinical Products)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Clinical Trial Biorepository & Archiving Solutions Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Product
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Product
    • 6.3.2. Canada Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Product
    • 6.3.3. Mexico Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Product

7. Europe Clinical Trial Biorepository & Archiving Solutions Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Product
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Product
    • 7.3.2. France Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Product
    • 7.3.3. United Kingdom Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Product
    • 7.3.4. Italy Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Product
    • 7.3.5. Spain Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Product

8. Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Product
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Product
    • 8.3.2. India Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Product
    • 8.3.3. Japan Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Product
    • 8.3.4. South Korea Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Product
    • 8.3.5. Australia Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Product

9. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Product
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Product
    • 9.3.2. UAE Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Product
    • 9.3.3. South Africa Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Product

10. South America Clinical Trial Biorepository & Archiving Solutions Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Product
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Product
    • 10.3.2. Colombia Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Product
    • 10.3.3. Argentina Clinical Trial Biorepository & Archiving Solutions Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Product

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Clinical Trial Biorepository & Archiving Solutions Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Azenta U.S., Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. Precision for Medicine, Inc.
  • 15.4. Medpace Holdings, Inc.
  • 15.5. Laboratory Corporation of America Holdings
  • 15.6. Q2 Solutions LLC
  • 15.7. Labconnect Inc.
  • 15.8. Charles River Laboratories International, Inc.
  • 15.9. Cell&Co SAS
  • 15.10. The Jackson Laboratory

16. Strategic Recommendations

17. About Us & Disclaimer